| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/05/2007 | EP1259541B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/05/2007 | EP0757716B1 Dna encoding bradykinin b1 receptor |
| 09/05/2007 | CN101031579A Pancreatic islet microrna and methods for inhibiting same |
| 09/05/2007 | CN101028524A Supersonic microvesicle target positioning controlled-release/gene device and target transferring method |
| 09/05/2007 | CN101028523A Method and compositions for the diagnosis and treatment of cancer |
| 09/05/2007 | CN101028522A Function and use of MNSF-beta gene during process of embryo nidation |
| 09/05/2007 | CN101028519A Pharmaceutical composition for treating immune diseases |
| 09/05/2007 | CN101028283A Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 09/05/2007 | CN100335637C Genetic immunization with nonstructural proteins of hepatitis c virus |
| 09/05/2007 | CN100335636C Thioredoxin gene of Schistosoma japonicum (Chinese Mainland Strain) and its cloning expression method and application |
| 09/05/2007 | CN100335499C C-terminal amino acid lactone modified extrasin alpha-1 and its uses |
| 09/05/2007 | CN100335137C Use of human homology cassette gene LHX4 in preparing medicine for treating phaeochromocytoma |
| 09/05/2007 | CN100335129C Mycobacterium triple nucleic acid vaccine for cattle |
| 09/04/2007 | US7265217 Expressing by means of a eukaryotic or prokaryotic vector, in which a nucleic acid coding for the mistletoe lectin polypeptide according to the usual genetic code or the fragment thereof is cloned in a suitable heterologous eukaryotic or prokaryotic host |
| 09/04/2007 | US7265209 CE7-specific chimeric T cell receptor |
| 09/04/2007 | US7265208 Autoimmune disease; allergies vaccine |
| 09/04/2007 | US7265097 Delivering therapeutic formulation containing sulphated chitinous polymer as a primary carrier across a membrane that has limited permeability for therapeutic agent |
| 09/04/2007 | US7265091 Methods and compositions for treating male erectile dysfunction |
| 09/04/2007 | US7265083 Administering to an animal a biologically effective amount of a pharmaceutically acceptable CXC chemokine formulation that comprises an XXX-CXC chemokine other than PF4, the XXX-CXC chemokine lacking the amino acid sequence ELR (Glu Leu Arg) |
| 09/04/2007 | US7264945 IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons |
| 09/04/2007 | US7264941 Diagnosing infections caused by C. pneumoniae, in pathology, in epidemiology, and as vaccine components |
| 09/04/2007 | US7264928 whereby a DNA sample is tested for the presence of polymorphic allele; solid phase synthesis |
| 09/04/2007 | US7264818 BAV packaging regions and E1 transcriptional control regions |
| 09/04/2007 | US7264800 Method and composition for inhibiting cancer cell growth |
| 09/04/2007 | US7264793 Numb protein expression inhibitors by Musashi |
| 08/30/2007 | WO2007098113A2 Ccr3 inhibition for ocular angiogenesis and macular degeneration |
| 08/30/2007 | WO2007097820A2 Viral gene products and methods for vaccination to prevent viral associated diseases |
| 08/30/2007 | WO2007097494A1 De-differentiation of astrocytes into neural stem cell using bmi-1 |
| 08/30/2007 | WO2007097492A1 De-differentiation of astrocytes into neural stem cell using nanog |
| 08/30/2007 | WO2007097358A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 08/30/2007 | WO2007096882A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 08/30/2007 | WO2007096382A2 Method for production of a transformed cell |
| 08/30/2007 | WO2007096278A1 Dendritic cells transiently transfected with a membrane homing polypeptide and their use |
| 08/30/2007 | WO2007096199A2 Differential diagnostics and therapy of virally induced heart muscle disease |
| 08/30/2007 | WO2007051267A8 Method for the production of recombinant virus, dna constructs, recombinant virus and vaccine compositions |
| 08/30/2007 | WO2007050643A3 Compositions and their uses for gene therapy of bone conditions |
| 08/30/2007 | WO2007024207A8 Enhanced zein reduction in transgenic corn seed |
| 08/30/2007 | WO2004009836A3 Pr/set-domain containing nucleic acids, polypeptides, antibodies and methods of use |
| 08/30/2007 | WO2000001393A8 OLIGONUCLEOTIDE INHIBITORS OF bcl-xL |
| 08/30/2007 | US20070203327 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substanaces |
| 08/30/2007 | US20070203095 Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid |
| 08/30/2007 | US20070203089 Compositions and methods for the treatment of ophthalmic disease |
| 08/30/2007 | US20070203088 Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease |
| 08/30/2007 | US20070203087 Chondroitin sulfate synthesis promoter |
| 08/30/2007 | US20070203086 Adenosine therapy via interfering RNA |
| 08/30/2007 | US20070203085 Methods For Interfering With Fibrosis |
| 08/30/2007 | US20070203084 Interfering Rna Duplex Having Blunt-Ends And 3'-Modifications |
| 08/30/2007 | US20070203083 Methods Of Regulating Metabolism And Mitochondrial Function |
| 08/30/2007 | US20070203082 RNAI Agents For Anti-SARS Coronavirus Therapy |
| 08/30/2007 | US20070203070 28 human secreted proteins |
| 08/30/2007 | US20070203064 TLR3 Glycosylation Site Muteins and Methods of Use |
| 08/30/2007 | US20070203061 Adiponectin expression-inducing agents and uses thereof |
| 08/30/2007 | US20070202599 contacting cells in vivo with composition comprising collagenous matrix of submucosa tissue delaminated from both tunica muscularis and luminal portion of tunica mucosa of warm-blooded vertebrates, and added exogenous deoxyribonucleic acid |
| 08/30/2007 | US20070202596 Selective antibody targeting of undifferentiated stem cells |
| 08/30/2007 | US20070202572 Microorganisms for therapy |
| 08/30/2007 | US20070202524 Targeted Vectors |
| 08/30/2007 | US20070202506 Single nucleotide polymorphisms predicting cardiovascular disease |
| 08/30/2007 | US20070202157 Delivery system for antisense oligonucleotides involves a liposomal composition, comprising a liposome which consists essentially of neutral phospholipids and an antisense oligonucleotide that is entrapped in the liposome |
| 08/30/2007 | US20070202120 Yellow Fever Mosquito Deoxyribonucleoside Kinases And Its Use |
| 08/30/2007 | US20070202119 Method Of Therapy |
| 08/30/2007 | US20070202117 Compositions and Methods Of Modulating the Immune Response |
| 08/30/2007 | US20070202115 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 08/30/2007 | US20070202114 Higher gene expression in sample indicates tumor is tamoxifen-resistant; drug screening |
| 08/30/2007 | US20070202112 Detecting vimentin expression and secretion and for characterizing cancer ( prostate cancer); |
| 08/30/2007 | US20070202111 Use of antibodies to the gamma 2 chain of laminin 5 to inhibit tumor growth and metastasis |
| 08/30/2007 | US20070202110 Angiogenesis Inhibiting Molecules And Their Use In The Treatment And Diagnosis Of Cancer |
| 08/30/2007 | US20070202109 Method Of Diagnosing Breast Cancer |
| 08/30/2007 | US20070202084 Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects |
| 08/30/2007 | US20070202082 Promoters for RNA interference |
| 08/30/2007 | US20070202081 Prevention And Treatment Of Vascular Disease With Recombinant Adeno-Associated Virus Vectors Encoding Apolipoprotein A-I And Apolipoprotein A-I Milano |
| 08/30/2007 | US20070202080 Gene Delivery System Containing Relaxin Gene And Pharmaceutical Composition Using Relaxin |
| 08/30/2007 | DE60215502T2 Verfahren zur Selektion einer Transkription-Modulatierenden DNA-Sequenz unter Verwendung einem Vektor mit einem Transkriptions-Repressions-Aktivem Element A method for selecting a transcription-Modulatierenden DNA sequence using a vector with a transcriptional repression active element |
| 08/30/2007 | DE60122300T2 Hepatitis b kernprotein fusionsproteine Hepatitis B core protein fusion proteins |
| 08/30/2007 | DE19627193B4 Rekombinantes myxomatisches Virus Recombinant virus myxomatisches |
| 08/30/2007 | CA2642999A1 Dendritic cells transiently transfected with a membrane homing polypeptide and their use |
| 08/30/2007 | CA2638829A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 08/30/2007 | CA2638122A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 08/30/2007 | CA2630218A1 Viral gene products and methods for vaccination to prevent viral associated diseases |
| 08/29/2007 | EP1826215A2 Method of obtaining the expression or improving the rate of expression of a gene |
| 08/29/2007 | EP1825859A1 Dendritic cells transiently transfected with a membrane homing polypeptide and their use |
| 08/29/2007 | EP1824519A2 Inhibition of li expression in mammalian cells |
| 08/29/2007 | EP1824518A2 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on proteins differentially expressed in serum |
| 08/29/2007 | EP1824517A2 Methods of treatment using melanopsin |
| 08/29/2007 | EP1465654A4 Plasmid mediated suplementation for treating chronically ill subjects |
| 08/29/2007 | EP1414961B1 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | EP1140997B1 Chlamydia trachomatis antigens |
| 08/29/2007 | EP1054963B1 Sequences of an ih ionic channel and the use thereof |
| 08/29/2007 | EP1032269B1 Treatment of neoplasms with interferon-sensitive, clonal viruses |
| 08/29/2007 | EP0935657B1 Modified steroid hormone receptors |
| 08/29/2007 | CN101027394A Modified oncolytic viruses |
| 08/29/2007 | CN101027081A Growth hormone releasing hormone enhances the immune response induced by vaccination |
| 08/29/2007 | CN101024845A 方法 Method |
| 08/29/2007 | CN101024831A A tumor necrosis factor related ligand |
| 08/29/2007 | CN101024090A Gene transfering compound and its preparing method |
| 08/29/2007 | CN101024089A Function of E4BP4 gene inplantation course and use thereof |
| 08/29/2007 | CN101024088A B-type hepatitis virus micro ribonucleic-acid interference moleculars and its designing method |
| 08/29/2007 | CN101024072A A composition for wound healing and use thereof |
| 08/29/2007 | CN100334219C Method for promoting ultrosonic mediated gene transfection by copolymer |
| 08/29/2007 | CN100333797C Novel use of tumor treating of recombinant adenoviral p53 products |